Reversal agents for non-vitamin K antagonist oral anticoagulants
Reversal agents for non-vitamin K antagonist oral anticoagulants
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
The non-vitamin K antagonist oral anticoagulants (NOACs) include dabigatran, which inhibits thrombin, and apixaban, betrixaban, edoxaban, and rivaroxaban, which inhibit factor Xa
Three NOAC reversal agents are in various stages of development: idarucizumab is licensed in many countries, andexanet is under consideration by regulator...
Alternative Titles
Full title
Reversal agents for non-vitamin K antagonist oral anticoagulants
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2023988859
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2023988859
Other Identifiers
ISSN
1759-5002
E-ISSN
1759-5010
DOI
10.1038/nrcardio.2017.223
